Highly touted efforts to cut health care spending, such as the recently passed One Big Beautiful Bill Act, ignore the real ...

One of the biggest challenges facing the cell and gene therapy (CGT) industry is attracting venture capital funding in an uncertain economic landscape. For advanced therapies, running clinical trials ...